INVESTMENT PORTFOLIO

We believe in and invest on disruptive and sustainable technologies.

US-based biotechnology company focused on developing artificial organ technologies to help patients with endocrine disorders such as diabetes, hypothyroidism, testosterone deficiency, and infertility.

The first anonymous DNA test kit with blockchain, it will allow users to participate and take advantage of the genomic revolution by maximizing privacy by using Blockchain networks to track all genomic data sets and reports (insights) without exposing their personal information.